Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Goodwill & Intangibles: 2011-2019

Historic Goodwill & Intangibles for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $29.5 million.

  • EyePoint Pharmaceuticals' Goodwill & Intangibles fell 56.80% to $29.5 million in Q1 2019 from the same period last year, while for Mar 2019 it was $29.5 million, marking a year-over-year decrease of 56.80%. This contributed to the annual value of $68.3 million for FY2018, which is 91.86% up from last year.
  • EyePoint Pharmaceuticals' Goodwill & Intangibles amounted to $29.5 million in Q1 2019, which was down 56.80% from $68.3 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $68.3 million for Q1 2018, and its period low was $718,000 during Q4 2016.
  • For the 3-year period, EyePoint Pharmaceuticals' Goodwill & Intangibles averaged around $47.2 million, with its median value being $36.3 million (2017).
  • In the last 5 years, EyePoint Pharmaceuticals' Goodwill & Intangibles spiked by 4,962.53% in 2017 and then tumbled by 56.80% in 2019.
  • EyePoint Pharmaceuticals' Goodwill & Intangibles (Quarterly) stood at $1.5 million in 2015, then slumped by 52.51% to $718,000 in 2016, then spiked by 4,962.53% to $36.3 million in 2017, then soared by 87.96% to $68.3 million in 2018, then plummeted by 56.80% to $29.5 million in 2019.
  • Its Goodwill & Intangibles was $29.5 million in Q1 2019, compared to $68.3 million in Q4 2018 and $68.3 million in Q3 2018.